Rock Springs Capital Management LP Q3 2020 Filing
Filed November 16, 2020
Portfolio Value
$3.9B
Holdings
148
Report Date
Q3 2020
Filing Type
13F-HR
All Holdings (148 positions)
| Stock | Value |
|---|---|
PRTAPROTHENA CORP PLC | $10.2M |
RYTMRHYTHM PHARMACEUTICALS INC | $10.1M |
TXG10X GENOMICS INC | $9.5M |
—RADIUS HEALTH INC | $9.2M |
—CHIASMA INC | $9.2M |
—PARATEK PHARMACEUTICALS INC | $9.1M |
NRIXNURIX THERAPEUTICS INC | $9.0M |
—TRANSLATE BIO INC | $8.7M |
—GAMIDA CELL LTD | $8.4M |
JAZZJAZZ PHARMACEUTICALS PLC | $8.2M |
—INTERSECT ENT INC | $8.2M |
WSTWEST PHARMACEUTICAL SVSC INC | $7.8M |
LEGNLEGEND BIOTECH CORP | $7.8M |
—ZOGENIX INC | $7.5M |
—IMARA INC | $7.3M |
—MYOVANT SCIENCES LTD | $7.2M |
ANNXANNEXON INC | $7.2M |
DVAXDYNAVAX TECHNOLOGIES CORP | $7.1M |
MGNXMACROGENICS INC | $6.6M |
—ODONATE THERAPEUTICS INC | $6.6M |
INSM 1.75 01/15/25INSMED INC | $6.5M |
BCELATRECA INC | $6.3M |
NGMUSDNGM BIOPHARMACEUTICALS INC | $5.7M |
XENEXENON PHARMACEUTICALS INC | $5.7M |
5E7ITEOS THERAPEUTICS INC | $5.6M |
GDRXGOODRX HLDGS INC | $5.6M |
—ACELRX PHARMACEUTICALS INC | $5.4M |
ACRSACLARIS THERAPEUTICS INC | $5.3M |
GRTXGALERA THERAPEUTICS INC | $5.1M |
—PANACEA ACQUISITION CORP | $4.8M |
—PHASEBIO PHARMACEUTICALS INC | $4.6M |
ANABANAPTYSBIO INC | $4.6M |
CYTKCYTOKINETICS INC | $4.5M |
—OBSEVA SA | $3.6M |
PSTXUSDPOSEIDA THERAPEUTICS INC | $3.3M |
—GLOBAL CORD BLOOD CORPORATIO | $3.2M |
TVTX 2.5 09/15/25RETROPHIN INC | $2.8M |
PASGPASSAGE BIO INC | $2.7M |
VRTXVERTEX PHARMACEUTICALS INC | $2.4M |
1K0IGM BIOSCIENCES INC | $1.5M |
NBIX 2.25 05/15/24NEUROCRINE BIOSCIENCES INC | $1.4M |
—THERAVANCE BIOPHARMA INC | $1.3M |
—FIVE PRIME THERAPEUTICS INC | $1.3M |
—RADIUS HEALTH INC | $1.2M |
—PACIRA BIOSCIENCES | $1.2M |
NVRO 2.75 04/01/25NEVRO CORP | $775K |
—NABRIVA THERAPEUTICS PLC | $569K |
BMY-RBRISTOL-MYERS SQUIBB CO | $417K |
PreviousPage 2 of 2